Cannara Biotech (TSX:LOVE) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.40) by 105 percent. This is a 50 percent decrease over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $27.179 million which missed the analyst consensus estimate of $31.700 million by 14.26 percent. This is a 2.23 percent increase over sales of $26.586 million the same period last year.